Anne-christine Andreasson
AstraZeneca BioPharmaceuticals R&D
Goeteborg, O, Sweden
Goeteborg, O, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Fibroblast activation protein and down-stream effects on its substrates in metabolic dysfunction-associated steatotic liver disease.
Journal: Scandinavian journal of gastroenterology
Published: June 03, 2026
Thermoneutrality accelerates a distinctive metabolic dysfunction-associated steatohepatitis phenotype in a diet-induced male mouse model with similarities to human disease.
Journal: Cellular and molecular gastroenterology and hepatology
Published: October 22, 2024
GLP-1R/GCGR dual agonism dissipates hepatic steatosis to restore insulin sensitivity and rescue pancreatic β-cell function in obese male mice.
Journal: Nature communications
Published: February 07, 2024
An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD).
Journal: Nature metabolism
Published: April 06, 2023
Elevated Adipocyte Membrane Phospholipid Saturation Does Not Compromise Insulin Signaling.
Journal: Diabetes
Published: March 28, 2022
Hepatic patatin-like phospholipase domain-containing 3 levels are increased in I148M risk allele carriers and correlate with NAFLD in humans.
Journal: Hepatology communications
Published: February 10, 2022
TLCD1 and TLCD2 regulate cellular phosphatidylethanolamine composition and promote the progression of non-alcoholic steatohepatitis.
Journal: Nature communications
Published: January 05, 2022
PSD3 downregulation confers protection against fatty liver disease.
Journal: Nature metabolism
Published: August 23, 2021
PCSK9 rs11591147 R46L loss-of-function variant protects against liver damage in individuals with NAFLD.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: June 19, 2020
Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice.
Journal: Molecular metabolism
Published: December 08, 2018
Last Updated: 09/26/2026